Table 2.

Univariate and multivariate analysis conducted for all patients

	OS				BCSS
	p (log rank)	HR (95% CI)	p (Cox)			p (log rank)	HR (95% CI)	p (Cox)
Age	< 0.001	2.271 (2.199–2.345)	< 0.001		0.001		1.284 (1.236–1.334)	< 0.001
Gender	< 0.001	0.697 (0.635–0.766)	< 0.001		< 0.001		0.851 (0.721–1.005)	0.057
Race	0.103	–	–		< 0.001		0.962 (0.928–0.997)	0.035
Grade	< 0.001	1.210 (1.191–1.230)	< 0.001		< 0.001		1.562 (1.522–1.603)	< 0.001
Laterality	0.021	0.988 (0.969–1.008)	0.253		0.081		–	–
Pathology	< 0.001	1.015 (1.004–1.026)	0.006		< 0.001		1.004 (0.987–1.022)	0.613
Stage	< 0.001	1.026 (0.965–1.090)	0.411		< 0.001		1.268 (1.160–1.385)	< 0.001
T-stage	< 0.001	1.553 (1.529–1.578)	< 0.001		< 0.001		1.748 (1.708–1.789)	< 0.001
ALN	< 0.001	0.778 (0.762–0.795)	< 0.001		< 0.001		0.834 (0.807–0.861)	< 0.001
ER-status	< 0.001	0.838 (0.810–0.867)	< 0.001		< 0.001		0.792 (0.756–0.830)	< 0.001
PR-status	< 0.001	0.783 (0.761–0.805)	< 0.001		< 0.001		0.658 (0.630–0.687)	< 0.001
Tumor extension	< 0.001	1.441 (1.379–1.506)	< 0.001		< 0.001		1.277 (1.205–1.354)	< 0.001
Chemotherapy	< 0.001	0.457 (0.463–0.487)	< 0.001		< 0.001		0.696 (0.671–0.722)	< 0.001
Radiation	< 0.001	0.612 (0.599–0.625)	< 0.001		< 0.001		0.672 (0.651–0.694)	< 0.001
Surgery	< 0.001	0.888 (0.810–0.867)	< 0.001		< 0.001		0.892 (0.864–0.922)	< 0.001
ALNS	< 0.001	1.203 (1.179–1.228)	< 0.001		< 0.001		1.290 (1.253–1.328)	< 0.001